Trading Your Own Way
Don't be greedy, share it:

Archive Monthly Archives: April 2020

AMD Stock Falters As Growth Outlook Sends Mixed Signals To Analysts

Advanced Micro Devices Inc. shares declined Wednesday after the chip maker cut the midpoint of its full-year growth sales outlook but held onto its gross margin outlook, prompting mixed views on the company’s trajectory. While some were encouraged that the chip maker still sees relatively fast growth ahead amid the COVID-19 pandemic, others worried that AMD […]

Continue reading

Ford and GM Stocks Stuck in Long-Term Downtrends

Ford Motor Company’s (F) first quarter 2020 earnings release on Tuesday evening offered few surprises, with America’s second largest auto manufacturer posting a loss of $0.23 per share on $34.3 billion in revenue. That marked a 14.9% year-over-year decline, beating revenue estimates that anticipated even fewer first quarter sales. The stock is up just three […]

Continue reading

Here Is Why Disney Stock Remains a Screaming Buy

With shares rebounding about 30% from their 52-week low, what’s next for Disney (NYSE:DIS) stock?Social distancing has been a tailwind for the company’s growing streaming business. However, shutdowns due to the novel coronavirus have been a big headwind for the company’s Theme Parks division. Like with many major stocks, investors remain on the fence whether tailwinds […]

Continue reading

Goldman Sachs: Buy These 10 Value Stocks to Beat the S&P 500

Goldman Sachs has named ten companies that investors should buy if they want a chance to beat the stock market this year. These include household names like Facebook, Alphabet, and Mastercard, all of which have balance sheets strong enough to survive a coronavirus recession. More interestingly, Goldman recommends lesser-known stocks like Monster Beverages and Regeneron Pharmaceuticals, […]

Continue reading

10 Stocks That Are Screaming Buys Right Now

For investors prepared to put in the work, there are plenty of gems to be found. I set out to pinpoint some of the hottest stocks to buy on the Street right now using the best analysts on Wall Street as guidance. TipRanks tracks and measures the performance of over 4,700 analysts, enabling investors to […]

Continue reading

Buy Netflix Stock as Long-Term Growth Remains in Motion

The novel coronavirus has been bad news for many stocks, but there are some exceptions. Take Netflix (NASDAQ:NFLX) stock for example. Not only have shares held steady as markets remain below their all-time highs, but the streaming powerhouse now trades well above where it was before the pandemic broke out.It’s obvious why the company has […]

Continue reading

This One Chart Makes The Case That The Worst Is Over For The Stock Market And The Virus Has Peaked

Is the worst behind the stock market after a coronavirus-induced rout? No one knows for sure as officials attempt to restart economies from a self-imposed period of hibernation to curb the spread of the contagion. However, a chart pairing the infections of the COVID-19 epidemic by growth rate and one of Wall Street’s most closely followed […]

Continue reading

S&P 500 Charts Are Telling Stock Investors To Downshift Into A Slower Gear

Stock market investors have reached nirvana. Governments have socialized losses but kept gains private. American society is being set up for endless profits in the stock market. That suits the rich and the 401(k) middle class. There is an implicit “put” (a protection from losses) in the stock market: That the Federal Reserve will start buying stocks […]

Continue reading

3 Stocks Trading at Attractive Valuations

In order to have higher chances to discover quality securities, investors could screen for the stocks of companies that have solid financial conditions and are expected to boost their profits. The following stocks trade near or below the Peter Lynch earnings line and have a return on invested capital (aka ROIC) that exceeds the weighted average […]

Continue reading

Inovio Pharmaceuticals – How to Trade the Stock

Inovio Pharmaceuticals (INO) spiked higher last week on the news that the biotech company received $6.9 million to finance its Phase 1/2 clinical trial in South Korea. The stock opened Monday at $15.78 and traded as high as $16.50 then faded below its weekly pivot at $15.77. Inovio’s gain the funds from the Coalition for Epidemic Preparedness […]

Continue reading
1 2 3 9